Zusammenfassung
Dieser Beitrag beschreibt allgemeine Behandlungsrichtlinien affektiver Störungen. Er ist damit spezifischer als Kap. 9 in Bd. 2 zu Allgemeinen Behandlungsprinzipien in der Psychiatrie und allgemeiner als die anschließende Darstellung spezifischer Behandlungsverfahren bei affektiven Erkrankungen in diesem Band (Kap. 23–25 und 31). Er arbeitet deren jeweiligen Stellenwert im Gesamtbehandlungsplan heraus und betont übergeordnete und gemeinsame Prinzipien.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Akiskal HS (1995) Mood disorders: introduction and overview. In: Kaplan HI, Sadock BJ (eds) Comprehensive textbook of psychiatry/VI, vol 1. Williams & Wilkins, Baltimore Philadelphia Hong Kong London Munich Sydney Tokyo, pp 1067–1079
Altshuler LL, Cohen L, Szuba MP, Burt VK, Gitlin M, Mintz J (1996) Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 153: 592–606
**APA (1993) Practice guideline for major depressive disorder in adults. Am J Psychiatry 150 (Suppl 4): 1–26
APA (1994a) Diagnostic and statistical manual of mental disorders, 4th revision (DSM-IV). American Psychiatric Press, Washington DC
**APA (1994b) Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 151 (Suppl 12): 1–36
Angst J (1995) The epidemiology of depressive disorders. Eur Neuropsychopharmacol Suppl: 95–98
Bauer M, Berghöfer A (1997) Leitlinien und praktische Durchführung der Pharmakotherapie mit Antidepressiva. In: Bauer M, Berghöfer A (Hrsg) Therapieresistente Depressionen. Springer, Berlin Heidelberg New York Tokio, S 170–184
**Bauer M, Döpfmer S (1999) Lithium augmentation in treatment-resistant depression — A meta-analysis of placebo-controlled studies. J Clin Psychopharmacol 19: 427–434
Bauer M, Strohde A (1999) Neue Behandlungsstrategien bei prophylaxeresistenten Bipolaren Störungen. Nervenarzt 70: 587–599
Bauer M, Hellweg R, Baumgartner A (1998a) Hochdosierte Thyroxinbehandlung bei therapie- und prophylaxeresistenten Patienten mit affektiven Psychosen. Nervenarzt 69: 1019–1022
*Bauer M, Hellweg R, Gräf KJ, Baumgartner A (1998b) Treatment of refractory depression with high dose thyroxine. Neuropsychopharmacology 18:444–455
Bauer M, Bschor T, Kunz D, Berghöfer A, Ströhle A, Müller-Oerlinghausen (1999) Lithium augmentation for continuation treatment of major depression: a placebo-controlled study. American College of Neuropsychopharmacology (ACNP), 38th Annual Meeting, Acapulco, Mexico, December 12–16, 1999
*Bauer MS, Whybrow PC (1990) Rapid cycling bipolar affective disorders. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study. Arch Gen Psychiatry 47: 435–440
*Bauer MS, Whybrow PC (1991) Rapid cycling bipolar disorder: Clinical features, treatment, and etiology. In: Amsterdam JD (ed) Advances in neuropsychiatry and psychopharmacology, vol 2: Re fractory depression. Raven, New York, pp 191–208
Baumgartner A, Bauer M, Hellweg R (1994): Treatment of intractable non-rapid cycling bipolar affective disorder with high-dose thyroxine: an open clinical trial. Neuropsychopharmacology 10: 183–189
*Beck AT (1967) Depression: clinical, experimental and theoretical aspects. Harper & Row, New York
Berghöfer A, Müller EB, Bauer M, Linden M, Mackert A, Müller- Oerlinghausen B, Helmchen H (1997) Sequentielle Behandlungs-strategien zur Vermeidung und Überwindung von Therapie-resistenz bei depressiven Erkran-kungen. In: Bauer M, Berghöfer A (Hrsg) Therapieresistente Depres-sionen. Springer, Berlin Heidel-berg New York Tokio, S 235–243
Bezchlibnyk-Butler KZ, Jeffries JJ (1996) Clinical handbook of psychotropic drugs, 6th edn. Hogrefe & Huber, Seattle
*Brunello N, Burrows GD, Jönsson CPB et al. (1995) Critical issues in the treatment of affective disorders. Depression 3: 187–198
Crismon ML, Trivedi M, Pigott TA et al. (1999) The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on medication treatment of major depressive disorder. J Clin Psychiatry 60: 142–156
Dilling H, Mombour W, Schmidt MH (1992) Internationale Klassifikation psychischer Störungen. ICD-10. Kapitel V (F). Klinisch-diagnostische Leitlinien. Huber, Bern
**Frank E, Kupfer DJ, Perel JM et al. (1990) Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 47: 1093–1099
Glassman AH, Shapiro PA (1998) Depression and the course of coronary artery disease. Am J Psychiatry 155: 4–11
Goodwin GM (1997) Treatment of bipolar depressive mood disorders: algorithms for pharmacotherapy. Int J Psychiatry Clin Pract HS9–S12
Greil W, Kleindienst N (1997) Rezi-divprophylaxe affektiver Störungen mit Lithium. In: Müller-Oer-linghausen B, Greil W, Berghöfer A (Hrsg) Die Lithiumtherapie — Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokio, S 190–218
Helmchen H (1974) Symptomatology of therapy-resistant depressions. Pharmacopsychiatry 7: 145–155
*Helmchen H (1990) Gestuftes Vorgehen bei Resistenz gegen Antidepressiva-Therapie. In: Möller HJ (Hrsg) Therapieresistenz unter Antidepressiva-Behandlung. Springer, Berlin Heidelberg New York Tokio, S 237–250
Heinz A (1997) Experimentelle Behandlungsansätze und Zukunftsperspektiven bei therapieresistenten Depressionen. In: Bauer M, Berghöfer A (Hrsg) Therapieresistente Depressionen. Springer, Berlin Heidelberg New York Tokio, S 235–243
*Hirschfeld RMA, Keller MB, Panico S et al. (1997) The national depressive and manic-depressive association consensus statement on the undertreatment of depression. JAMA 277: 333–340
Kasper S (1997) Treatment of unipolar major depression: Algorithms for pharmacotherapy. Int J Psychiatry Clin Pract 1: S5–S7
*Keller MB (1988) Undertreatment of major depression. Psychopharmacol Bull 24: 75–80
*Keller MB, Lavori PW, Rice J, Coryell W, Hirschfeld RMA (1986) The persistent risk of chronicity in recurrent episodes of nonbipolar major depressive disorder: a prospective follow-up. Am J Psychiatry 143: 24–28
**Kessler RC, McGonagle KA, Zhao S et al. (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 51: 8–19
*Klerman GL, Weissman MM (1992) The course, morbidity, and costs of depression. Arch Gen Psychiatry 49: 831–834
Klerman GL, Weissman MM, Rounsaville BJ, Chevron ES (1984) Interpersonal psychotherapy of depression. Basic Books, New York
**Kupfer DJ (1991) Long-term treatment of depression. J Clin Psychiatry 52 (Suppl 5): 28–34
* Kupfer DJ, Frank E, Perei JM et al. (1992) Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry 49: 769–773
Lebowitz BD, Pearson JL, Schneider LS et al. (1997) Diagnosis and Treatment of Depression in Late Life. Consensus Statement Update. JAMA 278: 1186–1190
Leonard BE (1993) The comparative pharmacology of new antidepressants. J Clin Psychiatry 54 (Suppl 8): 3–15
Leonard BE (1995) Mechanisms of action of antidepressants. CNS Drugs 4 (Suppl 1): 1–12
Linden M (1994) Therapeutic standards in psychopharmacology and medical decision making. Pharmacopsychiatry 27: 41–45
Linden M, Helmchen H, Mackert A, Müller-Oerlinghausen B (1994) Structure and feasibility of a standardized stepwise drug treatment regimen (SSTR) for depressed patients. Pharmacopsychiatry 27: 51–53
Linden M, Maier W, Achberger M, Herr R, Helmchen H, Benkert O (1996) Psychische Erkrankungen und ihre Behandlung in Allgemeinarztpraxen in Deutschland. Nervenarzt 67: 205–215
*Möller HJ. (1997) Therapieresistenz unter Antidepressiva: Definition, Epidemiologie und Risikofaktoren. In: Bauer M, Berghöfer A (Hrsg) Therapieresistente Depressionen. Springer, Berlin Heidelberg New York Tokio, S 3–15
Müller-Oerlinghausen B (1997) Depression als unerwünschte Arzneimittelwirkung. In: Bauer M, Berghöfer A (Hrsg) Therapieresistente Depressionen. Springer, Berlin Heidelberg New York Tokio, S 57–64
Nelson JC (1997) Augmentation strategies for treatment of unipolar major depression. In: Rush AJ (ed) Mood disorders. Systematic medication managment. Mod Probl Pharmacopsychiatry 25: 34–55
**Nierenberg AA, Amsterdam JD (1990) Treatment-resistant depression: definition and treatment approaches. J Clin Psychiatry 51 (Suppl 6): 39–47
*Nolen WA, Zohar J, Roose SP, Amsterdam J D (eds) (1994) Refractory depression: current strategies and future directions, Wiley, Chichester
Post RM, Denicoff KD, Frye MA, Leverich GS (1997) Algorithms for bipolar mania. In: Rush AJ (ed) Mood disorders. Systematic medication managment. Mod Probl Pharmacopsychiatry 25: 114–145
Prien RF, Kocsis JH (1995) Long-term treatment of mood disorders. In: Floyd EB, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven, New York, pp 1067–1079
Richelson E (1994) The pharmacology of antidepressants at the synapse: Focus on newer compounds. J Clin Psychiatry 55 (Suppl 9): 34–39
**Robins LN, Regier DA (1991) Psychiatric disorders in America: the epidemiological catchment area study. MacMillan, New York
Rudorfer MV, Potter WZ (1989) The new generation of antidepressants. In: Extein IL (ed) Treatment of tricyclic-resistant depression. American Psychiatric Press, Washington, pp 83–134
Schramm E, Berger M (1998) Störungsspezifische Psychotherapie bei Depression. Münch med Wochenschr 140: 306–313
Scott J (1988) Chronic depression. Br J Psychiatry 153: 287–297
Weissman MM, Klerman GL (1990) Interpersonal psychotherapy and its derivates in the treatment of depression. In: Manning DW, Frances AJ (eds) Combined pharmacotherapy and psychotherapy for depression. American Psychiatric Press, Washington DC
WHO (1991) Tenth revision of the International Classification of Diseases, Chapter V (F): Mental and behavioural disorders. WHO, Geneva
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bauer, M., Helmchen, H. (2000). Allgemeine Behandlungsprinzipien bei affektiven Störungen. In: Helmchen, H., Lauter, H., Henn, F., Sartorius, N. (eds) Psychiatrie der Gegenwart 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59626-1_22
Download citation
DOI: https://doi.org/10.1007/978-3-642-59626-1_22
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64057-5
Online ISBN: 978-3-642-59626-1
eBook Packages: Springer Book Archive